|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
340 |
0.50 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
440 |
0.49 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
440 |
0.49 |
Functional ≤ 10μM
|
Z50466-2-O |
Trypanosoma Cruzi (cluster #2 Of 8), Other |
Other |
1300 |
0.46 |
Functional ≤ 10μM
|
Z80120-4-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #4 Of 5), Other |
Other |
1440 |
0.45 |
Functional ≤ 10μM
|
Z80682-11-O |
A549 (Lung Carcinoma Cells) (cluster #11 Of 11), Other |
Other |
550 |
0.49 |
Functional ≤ 10μM
|
Z81135-3-O |
L6 (Skeletal Muscle Myoblast Cells) (cluster #3 Of 4), Other |
Other |
8100 |
0.40 |
Functional ≤ 10μM
|
Z81225-2-O |
M109 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
1000 |
0.47 |
Functional ≤ 10μM
|
Z81240-1-O |
MAC15A (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
9650 |
0.39 |
Functional ≤ 10μM
|
Z100094-1-O |
MLF (Lung Fibroblast Cells) (cluster #1 Of 1), Other |
Other |
4900 |
0.41 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.42 |
8.58 |
-23.57 |
1 |
2 |
1 |
20 |
233.294 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.81 |
8.79 |
-9.53 |
3 |
5 |
0 |
77 |
330.391 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.43 |
7.88 |
-9.85 |
3 |
5 |
0 |
77 |
316.364 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 36 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.48 |
Binding ≤ 10μM
|
EGFR-3-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
70 |
0.46 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8100 |
0.32 |
Binding ≤ 10μM
|
ERBB2-2-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
70 |
0.46 |
Binding ≤ 10μM
|
F16P1-1-E |
Fructose-1,6-bisphosphatase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.38 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8100 |
0.32 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6300 |
0.33 |
Binding ≤ 10μM
|
MK12-2-E |
MAP Kinase P38 Gamma (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6300 |
0.33 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6300 |
0.33 |
Binding ≤ 10μM
|
MK14-3-E |
MAP Kinase P38 Alpha (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
6300 |
0.33 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
630 |
0.39 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.37 |
Binding ≤ 10μM
|
VGFR2-2-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1489 |
0.37 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.53 |
Functional ≤ 10μM |
ERBB2-2-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
143 |
0.44 |
Functional ≤ 10μM
|
ERBB4-1-E |
Receptor Protein-tyrosine Kinase ErbB-4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
49 |
0.47 |
Functional ≤ 10μM
|
Z100492-1-O |
MCF10 (Normal Breast Epithelial Cells) (cluster #1 Of 1), Other |
Other |
211 |
0.42 |
Functional ≤ 10μM
|
Z100731-1-O |
Bcap37 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
8900 |
0.32 |
Functional ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
4400 |
0.34 |
Functional ≤ 10μM
|
Z80037-1-O |
Balb/MK (cluster #1 Of 1), Other |
Other |
200 |
0.43 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
4700 |
0.34 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
8900 |
0.32 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
820 |
0.39 |
Functional ≤ 10μM
|
Z80852-3-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
8310 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.06 |
8.59 |
-10.58 |
1 |
5 |
0 |
56 |
360.211 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 8 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KCNH2-2-E |
HERG (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
210 |
0.33 |
Binding ≤ 10μM
|
S22A1-1-E |
Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9940 |
0.25 |
Binding ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
720 |
0.31 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
ADO-1-E |
Aldehyde Oxidase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6400 |
0.26 |
ADME/T ≤ 10μM
|
CP2D6-2-E |
Cytochrome P450 2D6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7500 |
0.26 |
ADME/T ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
5890 |
0.26 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
600 |
0.31 |
Functional ≤ 10μM
|
Z50460-4-O |
Leishmania Major (cluster #4 Of 4), Other |
Other |
1500 |
0.29 |
Functional ≤ 10μM
|
Z80064-8-O |
CCRF-CEM (T-cell Leukemia) (cluster #8 Of 9), Other |
Other |
139 |
0.34 |
Functional ≤ 10μM
|
Z80084-1-O |
CEM-VLB (Vinblastine-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.31 |
Functional ≤ 10μM
|
Z80085-1-O |
CEM-VM1 (Etoposide-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
1910 |
0.29 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.45 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
4 |
0.42 |
Functional ≤ 10μM
|
Z80117-2-O |
DC3F/AD-II (cluster #2 Of 2), Other |
Other |
47 |
0.37 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
120 |
0.35 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
6 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
559 |
0.31 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
23 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.37 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
75 |
0.36 |
Functional ≤ 10μM
|
Z80227-2-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
1165 |
0.30 |
Functional ≤ 10μM
|
Z80244-7-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #7 Of 7), Other |
Other |
490 |
0.32 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
890 |
0.30 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
240 |
0.33 |
Functional ≤ 10μM
|
Z80608-4-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #4 Of 4), Other |
Other |
180 |
0.34 |
Functional ≤ 10μM
|
Z80612-1-O |
2008 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4310 |
0.27 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3520 |
0.27 |
Functional ≤ 10μM
|
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
220 |
0.33 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
1485 |
0.29 |
Functional ≤ 10μM |
Z80846-2-O |
F460pv8/eto Cell Line (cluster #2 Of 2), Other |
Other |
40 |
0.37 |
Functional ≤ 10μM
|
Z80889-2-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
210 |
0.33 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
700 |
0.31 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
80 |
0.35 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
901 |
0.30 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
9500 |
0.25 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
140 |
0.34 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1010 |
0.30 |
Functional ≤ 10μM
|
Z81284-2-O |
NCI-H647 (cluster #2 Of 2), Other |
Other |
70 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.91 |
6.33 |
-44.52 |
2 |
6 |
0 |
84 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.83 |
-16.62 |
2 |
6 |
0 |
80 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.94 |
-47.33 |
1 |
6 |
-1 |
82 |
392.46 |
5 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.93 |
5.12 |
-9.59 |
2 |
3 |
0 |
49 |
244.681 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.40 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.49 |
Functional ≤ 10μM
|
Z100501-1-O |
Lu1 (Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
80 |
0.52 |
Functional ≤ 10μM
|
Z103204-1-O |
A427 (cluster #1 Of 4), Other |
Other |
890 |
0.45 |
Functional ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
470 |
0.47 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
501 |
0.46 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
73 |
0.53 |
Functional ≤ 10μM
|
Z80008-2-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
890 |
0.45 |
Functional ≤ 10μM
|
Z80036-2-O |
BaF3 (IL-3-dependent Pro-B-cells) (cluster #2 Of 3), Other |
Other |
200 |
0.49 |
Functional ≤ 10μM
|
Z80145-1-O |
H69 (cluster #1 Of 4), Other |
Other |
1800 |
0.42 |
Functional ≤ 10μM
|
Z80156-10-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #10 Of 12), Other |
Other |
660 |
0.46 |
Functional ≤ 10μM
|
Z80164-3-O |
HT-1080 (Fibrosarcoma Cells) (cluster #3 Of 6), Other |
Other |
4300 |
0.40 |
Functional ≤ 10μM
|
Z80186-10-O |
K562 (Erythroleukemia Cells) (cluster #10 Of 11), Other |
Other |
380 |
0.47 |
Functional ≤ 10μM
|
Z80193-4-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 12), Other |
Other |
500 |
0.46 |
Functional ≤ 10μM |
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
430 |
0.47 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.49 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.42 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
800 |
0.45 |
Functional ≤ 10μM
|
Z80682-7-O |
A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other |
Other |
470 |
0.47 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
410 |
0.47 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
510 |
0.46 |
Functional ≤ 10μM
|
Z81115-3-O |
KB (Squamous Cell Carcinoma) (cluster #3 Of 6), Other |
Other |
812 |
0.45 |
Functional ≤ 10μM
|
Z81115-3-O |
KB (Squamous Cell Carcinoma) (cluster #3 Of 6), Other |
Other |
1780 |
0.42 |
Functional ≤ 10μM |
Z81170-5-O |
LNCaP (Prostate Carcinoma) (cluster #5 Of 5), Other |
Other |
3250 |
0.40 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
310 |
0.48 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z81277-1-O |
NCI-N417 (cluster #1 Of 2), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 4), Other |
Other |
2600 |
0.41 |
ADME/T ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 1), Other |
Other |
5010 |
0.39 |
ADME/T ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
190 |
0.50 |
ADME/T ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
3820 |
0.40 |
ADME/T ≤ 10μM |
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
5500 |
0.39 |
ADME/T ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
2070 |
0.42 |
ADME/T ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1820 |
0.42 |
ADME/T ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 1), Other |
Other |
3 |
0.63 |
ADME/T ≤ 10μM
|
Z81057-4-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #4 Of 5), Other |
Other |
370 |
0.47 |
ADME/T ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
5300 |
0.39 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.28 |
8.05 |
-7.84 |
1 |
2 |
0 |
29 |
246.313 |
0 |
↓
|
Lo
Low (pH 4.5-6)
|
4.28 |
8.52 |
-35.14 |
2 |
2 |
1 |
30 |
247.321 |
0 |
↓
|
|
|
Analogs
-
3675826
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.61 |
0.8 |
-8.21 |
1 |
3 |
0 |
42 |
251.285 |
3 |
↓
|
|